Loading
Latest filing published 14 Sept 2026 for BIOTALYS. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Gimax Consulting in Biotalys. The record holds 3 filings, for trades running from 22 August 2025 to 12 September 2026.
Market trades split into 2 purchases and 1 sale. No amount is published for 3 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and 1 sale.
The record was last updated on 14 September 2026 with an open-market sale in Biotalys. The last insider purchase was made public on 10 September 2026, 38 days ago. Between a trade and the moment it shows up on FSMA, the median delay is 3 days. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations